Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Dementia panel. NGS panel of 21 genes. Genologica Medica Spain | 44 | 21 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 2 | 1 |
|
Frontotemporal dementia and/or Amyotrophic Lateral Sclerosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 30 | 30 |
|
Inclusion Body Myopathy NGS Panel Fulgent Genetics United States | 21 | 5 |
|
Amyotrophic Lateral Sclerosis (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 25 | 30 |
|
AMYOTROPHIC LATERAL SCLEROSIS (ALS) (AUTOSOMAL DOMINANT) Laboratorio de Genetica Clinica SL Spain | 14 | 17 |
|
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Neuromuscular Disorders NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 233 | 144 |
|
Invitae Amyotrophic Lateral Sclerosis Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 29 | 21 |
|
Nonprevalent Amyotrophic Lateral Sclerosis Advanced Sequencing Evaluation Athena Diagnostics United States | 24 | 15 |
|
Amyotrophic Lateral Sclerosis Advanced Evaluation Athena Diagnostics United States | 19 | 17 |
|
CeGaT GmbH Germany | 2 | 1 |
|
CeGaT GmbH Germany | 32 | 36 |
|
Frontotemporal Dementia (FTD) Panel CeGaT GmbH Germany | 29 | 28 |
|
Amyotrophic Lateral Sclerosis (ALS) Panel CeGaT GmbH Germany | 29 | 54 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
Fulgent Genetics United States | 2 | 1 |
|
Distal Hereditary Myopathy NGS Panel Fulgent Genetics United States | 41 | 14 |
|
Fulgent Genetics United States | 5130 | 4674 |
|
Genome Diagnostics Laboratory University Medical Center Utrecht Netherlands | 28 | 15 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.